| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 05/27/2009 | EP2061775A2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN100491360C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538228 Transition metal complexes of ligands, e.g., oxzolines, bis-oxazolines, phosphine oxazolines and analgous thiazolines, imidazolines, pyrazolines; conformational rigidity for high enantioselectivity using bidentate ligands; catalyzed reactions include hydrogenation, hydrosilation, hydroboration and others |
| 05/26/2009 | US7538131 To modulate and control lipid and/or carbohydrate metabolism; atherosclerosis; acetic acid derivatives with cyclohexylmethoxy substituents; 2-[(1R,3S)-3-(2-Biphenyl-4-yl-5-methyloxazol-4-ylmethoxymethyl)cyclohexylmethoxy]-2-methylpropionic acid |
| 05/26/2009 | US7538130 Oxazole spiro derivative; easier, less expensive manufacture; incorporated in a coating composition for topcoat, clearcoat layers; against the effects of oxygen and light |
| 05/26/2009 | US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063505A2 Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide |
| 05/22/2009 | WO2009062371A1 Carbamate derivatives, and the use as medicament |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/21/2009 | US20090131679 Process for preparing oxazolidine derivatives |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090130020 Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols |
| 05/20/2009 | EP2059563A2 Fluoro-substituted benzoxazole polymethine dyes |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | CN101437805A Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 05/20/2009 | CN101434584A Chiral oxazolidinone compound with antibacterial activity |
| 05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/19/2009 | US7534804 N-(2-Benzooxazol-2-yl-ethyl)-4-pentyl-benzenesulfonamide; 15-lipoxygenase inhibitors; inflammation; diabetes; vascular restenosis; hypertension; asthma; rheumatiod arthritis; osteoarthritis; cancer; and inflammatory bowel disease |
| 05/19/2009 | US7534751 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners |
| 05/19/2009 | CA2382406C Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 05/14/2009 | WO2009061811A1 Substituted cyclopentanes having prostaglanding activity |
| 05/14/2009 | WO2009061233A1 Electroluminescent material containing an organic luminescent substance |
| 05/14/2009 | US20090124666 Trpv1 antagonists |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | CA2705150A1 Substituted cyclopentanes having prostaglandin activity |
| 05/13/2009 | EP2058305A1 Urea derivative |
| 05/13/2009 | EP1549624B1 Inhibitors of fatty acid amide hydrolase |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101429171A Synthesis of 3-aryl-4-vinyl oxazoline-2-ketone |
| 05/13/2009 | CN101429170A Biaryl heterocyclic compounds and methods of making and using the same |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/07/2009 | WO2009056811A2 Tetrahydrobenzothiazole derivatives with dopamine receptor activity |
| 05/07/2009 | WO2006044626A3 Thermoplastic articles for packaging uv sensitive materials, processes for the articles production and use and novel uv absorbers |
| 05/07/2009 | US20090118515 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118314 Tumor suppressor |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/06/2009 | EP2054384A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 05/06/2009 | EP2054368A2 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 05/06/2009 | EP1778655B1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1599453B1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 05/06/2009 | CN101426774A Azolecarboxamide derivative |
| 05/06/2009 | CN101426773A 5-phenyl-3-benzyl-oxazolidin-2-one derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders |
| 05/06/2009 | CN101426769A Five-membered heterocyclic invertebrate pest control agents |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/05/2009 | US7528404 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528120 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2009055749A1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2009054468A1 Azolecarboxamide compound or salt thereof |
| 04/30/2009 | WO2009054240A1 PROCESS FOR PRODUCTION OF DISULFONIC ACID COMPOUND, ASYMMETRIC MANNICH CATALYST, PROCESS FOR PRODUCTION OF β-AMINOCARBONYL DERIVATIVE, AND NOVEL DISULFONATE SALT |
| 04/30/2009 | WO2009053448A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 04/30/2009 | US20090111855 SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-alpha MODULATORS |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | DE102007047737A1 Piperidin- und Piperazinderivate Piperidine and piperazine derivatives |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | CA2703106A1 Azolecarboxamide derivatives as trka inhibitors |
| 04/30/2009 | CA2702976A1 2-aminooxazole derivatives as trpv1 antagonists useful for treating pain |
| 04/29/2009 | EP1828154B1 Phenyl-piperazin methanone derivatives |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482649C Organic compounds |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | US20090105484 Process for the preparation of aryl substituted oxazolidinones as intermediates for antibacterial agents |
| 04/23/2009 | US20090105447 Novel Polymers |
| 04/23/2009 | US20090105307 2-aminooxazolines as taar1 ligands |
| 04/23/2009 | US20090105273 Diacylglycerol Acyltransferase Inhibitors |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP2048951A2 Chemical compounds |
| 04/22/2009 | EP1768967B1 Novel intermediates for linezolid and related compounds |
| 04/22/2009 | EP1425266B1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments |
| 04/22/2009 | EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415694A Process for preparing linezolid |